Krystal Biotech buy Citigroup Inc.
Start price
06.01.26
/
50%
€216.00
Target price
06.01.27
-
Performance (%)
33.61%
Price
12.08.26
€288.60
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Krystal Biotech has seen massive gains of 33.61%. This prediction currently runs until 06.01.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 2.559% | 2.559% |
| iShares Core DAX® | 0.625% | 4.952% |
| iShares Nasdaq 100 | 1.160% | -1.160% |
| iShares Nikkei 225® | 2.356% | -1.354% |
| iShares S&P 500 | 0.631% | 1.380% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€233.70
12.01.26
12.01.26
€288.19
12.01.27
12.01.27
23.49%
12.08.26
12.08.26
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€179.60
27.02.25
27.02.25
14.14%
28.02.25
28.02.25